Cargando…

Clinical Efficacy and Safety of Qishen Yiqi Dropping Pill Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis

OBJECTIVE: The systematic review was designed to evaluate the safety and efficacy of Qishen Yiqi dropping pill combined with conventional Western medicine in the treatment of chronic heart failure (CHF). METHODS: Relevant randomized controlled trials (RCTs) investigating the clinical efficacy of Qis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lisheng, Wang, Ruilin, Liu, Honghong, Wei, Shizhang, Jing, Manyi, Wang, Min, Zhao, Yanling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872761/ https://www.ncbi.nlm.nih.gov/pubmed/33603818 http://dx.doi.org/10.1155/2021/6612653

Ejemplares similares

Protective effect of Qishen Yiqi dropping pills on the myocardium of rats with chronic heart failure
por: Lu, Yinghong, et al.
Publicado: (2019)

Antiplatelet Effects of Qishen Yiqi Dropping Pill in Platelets Aggregation in Hyperlipidemic Rabbits
por: Wang, Yi, et al.
Publicado: (2012)

Qishen Yiqi Drop Pill improves cardiac function after myocardial ischemia
por: JianXin, Chen, et al.
Publicado: (2016)

Efficacy of Qishen Yiqi Drop Pill for Chronic Heart Failure: An Updated Meta-Analysis of 85 Studies
por: Wang, Hao, et al.
Publicado: (2020)

Qishen Yiqi Dropping Pills Ameliorates Doxorubicin-Induced Cardiotoxicity in Mice via Enhancement of Cardiac Angiogenesis
por: Wang, Lijiang, et al.
Publicado: (2019)

Qishen Yiqi Drop Pill, a novel compound Chinese traditional medicine protects against high glucose‐induced injury in cardiomyocytes
por: Zhang, Shouyan, et al.
Publicado: (2019)

Qishen Yiqi dripping pills for ischemic heart failure: A protocol for a prospective cohort study
por: Zhao, Zhiqiang, et al.
Publicado: (2018)

The role of Qishen Yiqi dripping pills in treating chronic heart failure: An overview of systematic reviews and meta-analyses
por: Chen, Wensheng, et al.
Publicado: (2022)

Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
por: Wang, Mengxi, et al.
Publicado: (2021)

Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT‐IHF randomized clinical trial
por: Mao, Jingyuan, et al.
Publicado: (2020)

The Mechanism Research of Qishen Yiqi Formula by Module-Network Analysis
por: Zheng, Shichao, et al.
Publicado: (2015)

Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats
por: Luo, Ying, et al.
Publicado: (2022)

Efficacy and safety of Qishen Yiqi dripping pills as a complementary treatment for Heart Failure: A protocol of updated systematic review and meta-analysis
por: Guan, Hui, et al.
Publicado: (2021)

Qishen Yiqi dropping pills improve cardiomyocyte hypertrophy via the lncRNA TINCR/miR-193b-3p/RORA axis
por: Chen, Lei, et al.
Publicado: (2022)

Qishen Yiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats
por: Li, Shaohua, et al.
Publicado: (2022)

Metabolomics Profiles Associated with the Treatment of Zuojin Pill on Patients with Chronic Nonatrophic Gastritis
por: Ma, Xiao, et al.
Publicado: (2022)

Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF)
por: Hou, Ya Zhu, et al.
Publicado: (2013)

Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
por: Zhang, Qian, et al.
Publicado: (2021)

QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
por: Li, Meng, et al.
Publicado: (2022)

Based on Network Pharmacology to Explore the Potential Bioactive Compounds and Mechanisms of Zuojin Pill for the Treatment of Ulcerative Colitis
por: Wei, Ying, et al.
Publicado: (2021)

Treatment of Chronic Gastritis with Traditional Chinese Medicine: Pharmacological Activities and Mechanisms
por: Chen, Lisheng, et al.
Publicado: (2023)

Metabolomic Study of Zuojin Pill in Relieving 1-Methyl-3-nitro-1-nitrosoguanidine-Induced Chronic Atrophic Gastritis
por: Tong, Yuling, et al.
Publicado: (2021)

Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies
por: Ren, Sichen, et al.
Publicado: (2021)

Berberine inhibits IFN-γ signaling pathway in DSS-induced ulcerative colitis
por: Yang, Tao, et al.
Publicado: (2022)

Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Chen, Lisheng, et al.
Publicado: (2021)

A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Effect of Qishen Yiqi Dripping Pills on Exercise Endurance and Quality of Life in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention
por: Yu, Linghua, et al.
Publicado: (2021)

Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review
por: Wen, Jianxia, et al.
Publicado: (2020)

Network Pharmacology of Yougui Pill Combined with Buzhong Yiqi Decoction for the Treatment of Sexual Dysfunction
por: Wang, Yangyun, et al.
Publicado: (2019)

Efficacy and safety of Qishen granules for chronic heart failure: A protocol for systematic review and meta-analysis
por: Liu, Junjie, et al.
Publicado: (2020)

Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial
por: Wang, Jinping, et al.
Publicado: (2017)

A Network Pharmacology Approach to Explore the Mechanisms of Qishen Granules in Heart Failure
por: Liu, Junjie, et al.
Publicado: (2019)

Paeoniflorin Protects against ANIT-Induced Cholestatic Liver Injury in Rats via the Activation of SIRT1-FXR Signaling Pathway
por: Chen, Lisheng, et al.
Publicado: (2021)

Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway
por: Zhang, Jian, et al.
Publicado: (2019)

Network pharmacology-based study to explore the mechanism of the Yiqi Gubiao pill in lung cancer treatment
por: Li, Zheng, et al.
Publicado: (2021)

Qishen granules regulate intestinal microecology to improve cardiac function in rats with heart failure
por: Gao, Kuo, et al.
Publicado: (2023)

Corrigendum to “Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway”
por: Zhang, Jian, et al.
Publicado: (2020)

Decomposing the Mechanism of Qishen Granules in the Treatment of Heart Failure by a Quantitative Pathway Analysis Method
por: Ren, Weiquan, et al.
Publicado: (2018)

Efficacy and safety of Buzhong Yiqi decoction combined with western medicine in the treatment of myasthenia gravis: A protocol for systematic review and meta-analysis
por: Zong, Gang, et al.
Publicado: (2021)

Huanglian Jiedu Decoction Exerts Antipyretic Effect by Inhibiting MAPK Signaling Pathway
por: Li, Xing, et al.
Publicado: (2021)

The Protective Effect of Qishen Granule on Heart Failure after Myocardial Infarction through Regulation of Calcium Homeostasis
por: Yang, Xiaomin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6pbu8hlgij6tg1tc0760lgaus0